Prevalence of a V2 epitope in clade B primary isolates and its recognition by sera from HIV-1-infected individuals
- PMID: 9110092
Prevalence of a V2 epitope in clade B primary isolates and its recognition by sera from HIV-1-infected individuals
Similar articles
-
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity.AIDS. 2006 Oct 3;20(15):1923-30. doi: 10.1097/01.aids.0000247113.43714.5e. AIDS. 2006. PMID: 16988513
-
Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.J Med Virol. 1999 Oct;59(2):169-79. J Med Virol. 1999. PMID: 10459152
-
Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.Virology. 1997 Mar 17;229(2):360-9. doi: 10.1006/viro.1997.8443. Virology. 1997. PMID: 9126249
-
Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates.J Med Virol. 2000 Sep;62(1):14-24. J Med Virol. 2000. PMID: 10935983
-
Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity.J Immunol. 1997 Nov 15;159(10):5114-22. J Immunol. 1997. PMID: 9366441
Cited by
-
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.J Virol. 2018 Mar 28;92(8):e01843-17. doi: 10.1128/JVI.01843-17. Print 2018 Apr 15. J Virol. 2018. PMID: 29386288 Free PMC article.
-
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.PLoS One. 2013;8(1):e53629. doi: 10.1371/journal.pone.0053629. Epub 2013 Jan 17. PLoS One. 2013. PMID: 23349725 Free PMC article. Clinical Trial.
-
Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopes.PLoS One. 2010 Dec 29;5(12):e15994. doi: 10.1371/journal.pone.0015994. PLoS One. 2010. PMID: 21209919 Free PMC article.
-
The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.J Virol. 2004 Mar;78(5):2394-404. doi: 10.1128/jvi.78.5.2394-2404.2004. J Virol. 2004. PMID: 14963135 Free PMC article.
-
Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals.Virology. 2012 Jun 5;427(2):198-207. doi: 10.1016/j.virol.2012.02.003. Epub 2012 Mar 7. Virology. 2012. PMID: 22402248 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical